Dependence on dextromethorphan hydrobromide.

Design and evaluation of taste masked dextromethorphan hydrobromide oral disintegrating tablets.

The present study is aimed to develop dextromethorphan hydrobromide (DXM) oral disintegrating tablets (ODT) with acceptable palatability to help patients of all age groups. The bitter taste of the drug was masked by binding the drug to ion exchange resin. The effect of the particle size of resin on drug loading was studied. In vitro and in vivo disintegration time and in vitro drug release stud...

Evaluation the effects of dextromethorphan and midazolam on morphine induced tolerance and dependence in mice.

The main aim of this study was to evaluate the effects of dextromethorphan and midazolam and their combination on morphine tolerance and dependence in mice. In the present study, different groups of mice were rendered randomly and received morphine (50 mg kg(-1), s.c.), morphine (50 mg kg(-1), s.c.) + Dextromethorphan (25, 50 and 75 mg kg(-1), i.p.), morphine (50 mg kg(-1), s.c.) + midazolam (0...

Polymorphic Study of (-)-galanthamine Hydrobromide

Preparation of Arsenobetaine hydrobromide

Crystalline arsenobetaine hydrobromide is deposited directly on addition of trimethylarsine to a benzene solution of bromoacetic acid. The product is stable, non-deliquescent and may be readily converted into the free betaine by passage through basic ion exchange resin.

Antioxidant properties of galantamine hydrobromide.

The antioxidant properties of galantamine hydrobromide ((4alpha,6beta)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol hydrobromide) were studied in vitro, using luminol-dependent chemiluminescence and spectrophotometry. It was found that this compound was a scavenger of reactive oxygen species (ROS). By comparing the antioxidant effects of galantamine ((...